Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cochlear ( (AU:COH) ) has shared an announcement.
Cochlear Limited has announced the application for the quotation of new securities on the Australian Securities Exchange (ASX). This move involves the issuance of fully paid ordinary securities under an employee incentive scheme, reflecting the company’s ongoing efforts to align employee interests with corporate growth. The announcement indicates Cochlear’s strategic focus on enhancing its market presence and operational capabilities, potentially impacting its stakeholders positively by fostering a more engaged workforce.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$311.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company focuses on providing advanced hearing technologies to improve the quality of life for individuals with hearing loss.
Average Trading Volume: 173,116
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$20.4B
Learn more about COH stock on TipRanks’ Stock Analysis page.